NVSEF Novartis AG

Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines to enhance health outcomes for patients and health-care providers. This segment also commercializes products in the areas of oncology and rare diseases, ophthalmology, immunology and dermatology, neuroscience, respiratory, cardio-metabolic, and established medicines. The Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in the areas of cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapies, metabolism, oncology, ophthalmic, pain, and respiratory; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The Alcon segment offers eye care products, such as eye care devices for cataract, retinal, glaucoma, and refractive surgery, as well as intraocular lenses to treat cataracts and refractive errors; viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery; and contact lenses, as well as contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Intellia Therapeutics; Caribou Biosciences; Bristol-Myers Squibb; IBM Watson Health; Amgen; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; and PEAR Therapeutics. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol VX:NOVN.

$90.49    Pink
As of 01/14/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  Switzerland
Country of incorporation:  Switzerland
IPO date:  11/30/2018
Outstanding shares:  2,434,420,920
Average volume:  15,756
Market cap:   $220,607,223,770
Current dividend yield:  3.56%
Sedol:      B01DMY5
Valuation   (See tab for details)
PE ratio:   22.46
PB ratio:   3.57
PS ratio:   4.21
Return on equity:   17.27%
Net income %:   18.72%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy